Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Let me guess he'll then message saying he's sold but still thinks the share will reach £20. Stick to £5 share price and hope for the best.
LOL. This board really is a waste of ****ing time.
Not this again. Who unleashed MB and his O*X love on here....stick to what you’re invested in. If the COViD stuff falls flat on its face at least we have a whole other business to focus on, one that we originally set out to develop.
Comments made to me......
Without source that’s rumour, and if it’s from someone with non public info that’s naughty.
It’s a nice post. 99% ramp/ guesses, ignores that Avacta have almost 0 operational ability and that the 120 million number is Inthink Als number. It’s a guess at what he thinks is needed to control the virus not an official target. Avacta won’t get 100%, PCR will still be used and other tests coming online.
But nice post if you are wanting to see price move up quickly, seen better analysis from others thou, just not dressed up in a”we are predicting “ type phrasing.
Here’s my analysis. If/when tests gets produced, Avacta will make so much money it will makes today’s valuation look silly. They will sell every test they can make over next 12 months.Getting production up will take time. Avacta will be a take over target, north of 3 billion just for diagnostics if test ships abs is certified.
Most importantly it will provide a proactive method of tackling rising infections and give me a chance to give mum and dad a hug . Go team Avacta !
Suggesting comments about £1bn monthly revenues and multi Billion pound valuations being premature seeing as there is no commercial test is hardly attacking it.
He is now running his own book, so to speak. He has a vested interest and one would expect, no access to any privileged information. He may have called a couple of things correctly. However, so does Global (albeit after the fact) Here's a thought, a LFD isn't just binary, it can signal more than one result, including +- for antigens and antibodies. That would be the 'ring to unite all rings' I do agree that we need to see something soon. I expect, when it does arrive, and it will, it will be the de facto global standard.
We know a lot more about our tests than you know about any of Mologics tests (even the one that failed to impress at Heathrow) Merchant Banker.
And as for the rtc tests can you really trust the 2 Ulster University Reports standing the fact that no one has ever disclosed the results of the one that deals with its suitability for home use and in respect of the one which purports to deal with the sensitivity of the test the methodology included binning a significant proportion of the tests.
It will be interesting to see what PHE makes of all that. No wonder the MHRA are dragging their heels.
And re the small Government order well they are ordering any old tat at the moment.
Despite all the above you at ODX will make lots of money like us at AVCT but don't come to us from your glass house and throw stones!
What I don't understand is if you have 0.9% of a company's stock do you not have to be careful about avoiding accusations of market manipulation when you comment in public forums. If you were doubling up on 750,000/shares again you think you would be avoiding comment.
It’s the equivalent of me buying a lottery ticket for a £50m rollover and valuing my ticket at £50m the day before the draw assuming I’m going to win.
This really needs proof the test can deliver before taking about fractions of those numbers. If you are going by BAMS and Elisa as a sign of success for the lateral flow, I’d be worried.
Do me a favour if it reaches these kind of valuations make sure you go out and have the time of your lives with your profits as it will be well earned.
*clinical validation excuse the error
Not doing clinical trials, that's a totally different path.
Obs reffering about quasimodo's ugly brother
Call Myles a ramper if you like, but he has been proven right before. Firstly, anybody who bought into Avacta following his original tip about the company has done VERY well.
Secondly, some of you may recall that a few months back he said that he expected Avacta to release another type of test. Sure enough, up popped ELISA out of nowhere. There was absolutely no prior indication that was going to happen. Luck maybe, but doesn't seem likely.
I really rate the guy. I've been following him for a while and I don't recall seeing him making incorrect predictions on any share.
Seriously, so what...Is he running the company now & know’s more than the rest of us?
The cynic in me thinks the pandemic will have a cure by then.. but all the major pharmas have rinsed placings to secure their future... now I id hear billions and billions once.. but maybe it was meant to be millions and millions in placings
Has Myles just officially moved the timeline for the lft test to March 2021 from Al’s Q4 2020.
Merchant, why don’t you and mortgage grab a room and a broadband connection.
Think of the fun you could have...
Damn, I thought we’d seen the last of ****ney Rhyming Slang?
I’ve seen some ramps in my time that’s different level!! 1bn revenues per month. Multi billion valuation..... I mean come on.... not even gone through clinical trials yet
Chengdo - does it begin with an M or a B? I'm guessing the former....
Myles mentions 120m tests per month first quarter 2021. Where does this number come from? In the presentation of 29th of September there is a slide that points to BBI and Abingdon which says 'several million strips'. I can imagine there will be partnerships with other producers, but those haven't materialised yet.
Chengdo, I’m very disappointed, if you’re going to cross ramp, at least make it easy and make some sort of pun
I'm finally in the blue on that other company today Cheng and very optimistic.
Interesting part in it for me was the comments re Tech Transfer - 95/5
Am a big Myles fan as you all know but that is way over the top ramptastic posts, against backdrop of continued delays and no official news from Sir Al. Best for Myles if he has any contacts with Avacta to post some snippets of info which may give some guidance to wtf is going on.
Thanks BBBB